Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization

Langenhan et al. 10.1073/pnas.0503270102.

Supporting Information

Files in this Data Supplement:

Supporting Text
Supporting Table 1
Supporting Figure 5
Supporting Table 2
Supporting Figure 6
Supporting Table 3
Supporting Table 4
Supporting Table 5




Supporting Figure 5

Fig. 5. Hydrolytic stability of neoglycoside 4a.





Supporting Figure 6

Fig. 6. Reciprocal IC50 values as a function of library member and cell line. Standard errors are depicted with error bars.





Table 1. Liquid chromatography/mass spectrometry information for neoglycoside library

Neo-glycoside

Calculatedmass, Da

Observedmass, Da

Purity, %

90% isomeric purity

Neo- glycoside

Calculated mass, Da

Observed mass, Da

Purity, %

90% isomeric purity

4b

566.7

566.7

97

+

4a

566.7

566.7

98

+

5b

536.6

536.6

98

5a

536.6

536.6

100

6b

536.6

536.6

99

6a

536.6

536.6

99

+

7b

550.7

550.7

97

+

7a

550.7

550.7

96

8b

550.7

550.7

100

+

8a

550.7

550.7

99

9b

550.7

550.7

21

9a

550.7

550.7

0

10b

550.7

550.7

100

10a

550.7

550.7

97

11b

548.7

548.7

100

+

11a

548.7

548.7

100

+

12b

568.6

568.6

88

12a

568.6

568.6

95

+

13b

568.6

568.6

100

+

13a

568.6

568.6

100

+

14b

536.6

536.6

97

+

14a

536.6

536.6

99

+

15b

536.6

536.6

95

+

15a

536.6

536.6

99

+

16b

568.5

568.5

91

16a

568.5

568.5

99

17b

566.7

566.7

100

17a

566.7

566.7

95

18b

566.7

566.7

98

+

18a

566.7

566.7

98

+

19b

566.7

566.7

65

19a

566.7

566.7

94

20b

566.7

566.7

88

20a

566.7

566.7

91

21b

566.7

566.7

96

21a

566.7

566.7

91

22b

566.7

566.7

93

22a

566.7

566.7

92

23b

536.6

536.6

99

+

23a

536.6

536.6

100

+

24b

536.6

536.6

99

+

24a

536.6

536.6

97

+

25b

566.7

566.7

89

+

25a

566.7

566.7

93

+

26b

566.7

566.7

90

26a

566.7

566.7

91

27b

566.7

566.7

88

27a

566.7

566.7

91

28b

566.7

566.7

52

28a

566.7

566.7

61

29b

566.7

566.7

61

29a

566.7

566.7

34

30b

548.7

548.7

98

+

30a

548.7

548.7

97

+

31b

578.7

578.7

62

31a

578.7

578.7

86

32b

536.6

536.6

96

+

32a

536.6

536.6

98

33b

354.6

354.6

98

+

33a

354.6

354.6

99

34b

607.7

607.7

97

34a

607.7

607.7

99

35b

728.8

728.8

92

+

35a

728.8

728.8

88

+

36b

728.8

728.8

64

+

36a

728.8

728.8

89

+

37b

728.8

728.8

96

+

37a

728.8

728.8

97

+

38b

580.7

580.7

70

38a

580.7

580.7

22

39b

566.7

566.7

89

+

39a

566.7

566.7

96

+

40b

566.7

566.7

96

+

40a

566.7

566.7

97

+

41b

562.7

562.7

87

41a

562.7

562.7

83

42b

566.7

566.7

89

+

42a

566.7

566.7

98

+





Table 2. Library member IC50 values (μM) and standard errors

Cells

 

L- riboside (5b )

D- riboside (6b )

L- fucoside (7b )

D-fucoside (8b )

2-Deoxy-D- galactoside (9b )

3-deoxy-D- glucoside (10b )

6-Deoxy-D- glucoside (11b )

2-Deoxy-2-fluoro-D- glucoside (12b )

6-Deoxy-6-fluoro-D- glucoside (13b )

Du145

IC50

0.30

0.72

0.7

3.9

7

0.8

6

9

5

SE

0.03

0.04

0.1

0.6

1

0.2

1

2

2

MCF7

IC50

0.19

3.0

1.3

11

5.1

0.46

1.9

8

6.2

SE

0.03

0.4

0.4

2

0.8

0.09

0.2

1

0.9

HCT-116

IC50

0.018

1.3

1.2

7

10

1.8

2.3

8

4.8

SE

0.002

0.6

0.3

1

1

0.4

0.4

2

0.8

Hep 3B

IC50

0.059

0.9

0.35

4.9

3.6

1.7

4.4

8

4.6

SE

0.006

0.1

0.04

0.3

0.8

0.2

0.4

1

1.0

SF-268

IC50

0.23

1.8

0.90

10

8